GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,790.60p
   
  • Change Today:
      4.00p
  • 52 Week High: 1,824.40
  • 52 Week Low: 1,380.40
  • Currency: UK Pounds
  • Shares Issued: 5,084m
  • Volume: 2,807,487
  • Market Cap: £91,037m
  • RiskGrade: 129

GSK Overview

UK-based GSK Plc is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book n/a  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

GSK Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-17 30,186.00 3,525.00 111.80p 11.8 1.3 +9% 80.00p 6.0%
31-Dec-18 30,821.00 4,800.00 119.40p 12.5 1.8 +7% 80.00p 5.4%
31-Dec-19 33,754.00 6,221.00 123.90p 14.4 3.6 +4% 80.00p 4.5%
31-Dec-20 34,099.00 6,968.00 115.90p 11.6 n/a -6% 80.00p 6.0%
31-Dec-21 34,114.00 5,442.00 113.20p 14.2 n/a -2% 80.00p 5.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GSK Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-22 36,151.23 8,455.18 121.60p 14.7 2.0 +7% 52.27p 2.9%
31-Dec-23 37,226.22 9,277.35 130.39p 13.7 1.9 +7% 53.78p 3.0%

Copyright © 2022 FactSet Research Systems Inc. All rights reserved.

GSK Company Announcements

Director/PDMR Shareholding 06-Jul-2022 10:11 RNS
GSK disclose discontinued operations from Q2 2022 05-Jul-2022 12:43 RNS
Director/PDMR Shareholding 05-Jul-2022 09:45 RNS

GSK ShareCast News

Covid-19 cases surge during latest week due to B... 01-Jul-2022 ShareCast
GSK submits shingles vaccine application in Japa... 28-Jun-2022 ShareCast
GlaxoSmithKline to invest £1bn in infectious dis... 23-Jun-2022 ShareCast

GSK Top Newspaper Links

GSK invests £1bn to fight neglected tropical dis... 24-Jun-2022 Times
GlaxoSmithKline scraps sale of old drugs 05-Dec-2014 Telegraph
Glaxo sharpens axe to save £1bn as insurers and ... 01-Dec-2014 The Independent

Latest GSK Director Deals

Traded Action Notifier PriceAmountValue
04-Jul-22 Transfer From Emma Walmsley 0.000p 7 £0.00
04-Jul-22 Buy Emma Walmsley 1,798.94p 7 £125.93
01-Jul-22 Buy Dividends Emma Walmsley 1,762.90p 20 £352.58

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

GSK Market Data

Currency UK Pounds
Share Price 1,790.60p
Change Today 4.00p
% Change 0.22 %
52 Week High 1,824.40
52 Week Low 1,380.40
Volume 2,807,487
Shares Issued 5,084m
Market Cap £91,037m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
81.19% above the market average81.19% above the market average81.19% above the market average81.19% above the market average81.19% above the market average
87.30% above the sector average87.30% above the sector average87.30% above the sector average87.30% above the sector average87.30% above the sector average
Income Not Available
Growth
71.43% below the market average71.43% below the market average71.43% below the market average71.43% below the market average71.43% below the market average
90% below the sector average90% below the sector average90% below the sector average90% below the sector average90% below the sector average

What The Brokers Say

Strong Buy 7
Buy 1
Neutral 12
Sell 0
Strong Sell 1
Total 21
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 19-May-22 24-Feb-22
Paid 01-Jul-22 07-Apr-22
Amount 14.00p 23.00p

Trades for 06-Jul-2022

Time Volume / Share Price
11:36 203 @ 1,790.40p
11:36 53 @ 1,790.60p
11:36 24 @ 1,790.60p
11:36 24 @ 1,790.60p
11:36 24 @ 1,790.60p

GSK Key Personnel

CEO Emma Walmsley
CFO Iain Mackay

Top of Page